| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
09-22-2010, 04:09 PM
|
#1 | |||
|
||||
|
Grand Magnate
|
Just saw on the CNN medical news site that the FDA has approved finglimod -- the first oral MS drug. They are calling it gilenya. I have mixed feelings about this. I am glad that it has been approved, but nervous about trying a new treatment given my past history with the CRAB's and tysabri. I know the last time I saw my neuro he had mixed feelings about putting me on any new treatment considering my history and the fact that I have been relatively stable.
So who is considering trying it? |
|||
|
 Reply With Quote
|
| "Thanks for this!" says: | dmplaura (12-09-2010), Lady (09-22-2010), Natalie8 (09-22-2010), NurseNancy (11-24-2010), SallyC (09-22-2010), TRESA (11-10-2010), Twinkletoes (09-22-2010) |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| What I learned about fingolimod today | Multiple Sclerosis | |||
| new information on Gilenia (Fingolimod) | Multiple Sclerosis | |||
| Novartis had changed the name of Fingolimod to Gilenia (aka FTY720). | Multiple Sclerosis | |||
| FTY720/Fingolimod | Multiple Sclerosis | |||
| Fingolimod/FTY720 Research from ECTRIMS | Multiple Sclerosis | |||
Gilenya -- fingolimod
Threaded Mode